- ESSA Pharma (NASDAQ:EPIX): Q1 GAAP EPS of -$0.36.
- At March 31, 2021, the Company had available cash reserves and short-term investments of $208,597,224 reflecting the gross proceeds of the February 2021 financing of $150.0 million and July 2020 financing of $48.9 million, less operating expenses in the intervening period.
- Press Release